Immunosuppressants protein tyrosine kinase Neuronal Signaling PI3K / Akt / mTOR Metabolism Cell Cycle Epigenetics Cytoskeletal Signaling Angiogenesis DNA damage Proteases Apoptosis Mitogen-activated protein kinase (MAPK) Endocrinology & Hormones GPCR & G Protein Transmembrane Transporters Protein tyrosine kinase /JAK / STAT TGF-beta / Smad Stem Cells & Wnt Nuclear transcription factor (NF-κB) Ubiquitin Microbiology Autophagy
ChemicalBook >   Product Catalog >  Biochemical Engineering >  Inhibitors

Inhibitors

Immunosuppressants protein tyrosine kinase Neuronal Signaling PI3K / Akt / mTOR Metabolism Cell Cycle Epigenetics Cytoskeletal Signaling Angiogenesis DNA damage Proteases Apoptosis Mitogen-activated protein kinase (MAPK) Endocrinology & Hormones GPCR & G Protein Transmembrane Transporters Protein tyrosine kinase /JAK / STAT TGF-beta / Smad Stem Cells & Wnt Nuclear transcription factor (NF-κB) Ubiquitin Microbiology Autophagy
More
Less

Inhibitor refers to substance that can hinder the chemical reactions, biological reactions (including immune response) and biological activity. In present time, commonly used inhibitors include immunosuppressants and inhibitors.

1. Immunosuppressive agents: immunosuppressants system refers to drug that can reduce the immune response. It can selectively suppress certain steps of the immune response and immune cells. Immune response refers to the body’s response to a variety of pathogenic substances. Some reactions are favorable to the body and can enhance the body's resistance to disease; some have adverse effects on the body and can cause tissue damage or disorders of physiological functions (allergy). Therefore, patients suffering from allergic reactions being harmful to the body should be subject to the treatment of immunosuppressant to affect the related immune processes and reduce the immune response of the body.

For the treatment of various autoimmune diseases and weakening the tissue incompatibility, it has been developed of a variety of immunosuppressive agents, some of which have been widely used in clinical practice. Commonly used immunosuppressants include glucocorticoids (prednisone, prednisolone, etc.), alkylating agents (nitric oxide mustard, cyclophosphamide, thiotepa, busulfan, etc.), and antimetabolites (6- mercaptopurine, azathioprine, methotrexate, etc.).

The mechanism of immunosuppressants, though not entirely clear, but is characterized by the following several aspects:
① most kinds of immunosuppressants can simultaneously inhibit cellular and humoral immunity and can be used for organ transplantation and autoimmune disease.
②Its inhibitory effect is strong for the primary immune response while the inhibitory effect against secondary response is weak.
③It can simultaneously act on normal and pathological immunity, therefore, can often lead to some complications.
④These drugs often have strong with serious adverse reactions.

2. Enzyme inhibitors: Enzyme inhibitors refer to compounds or drugs being capable of binding to enzyme and inhibit the enzymatic activity. It is clinically often applied of enzyme inhibitors to specially interfere with certain metabolic system to achieve the therapeutic purposes. For example, people use monoamine oxidase inhibitors as antidepressants; use carbonic anhydrase inhibitors as diuretics; use dopa decarboxylase inhibitors as antihypertensive drugs and use antibiotics such as penicillin, cephalosporins belonging to cell wall synthesis inhibitors. Enzyme inhibitors have applications in veterinary medicine and agriculture. In addition, people can also apply enzyme inhibitors to study the mechanism of the enzyme and metabolic pathways.

Enzyme inhibitors often have similar structure with their natural substrates. For designing the inhibitors according modification of natural substrate, people should first analyze and decide the function of each part of the molecule in binding with enzymes: for binding or not binding or repulsion; secondly, people should know the degree of tolerance of the binding site to the adjacent steric hindrance. Then people can replace each functional group to regulate the strength of interaction with the enzyme.

Inhibitors can be divided into reversible and irreversible, two classes. (1)Inhibitors binding with enzyme through non-covalent bonds are called reversible inhibitor. (2)Inhibitors binding to the enzyme via a covalent bond are irreversible inhibitors with strong binding affinity. They will not be affected by concentration change process such as dialysis or dilution after binding to the enzyme.

Click on the specific product, view the latest prices of the products, information, serving information

Structure:
Chemical Name:
ODM-201
CAS:
1297538-32-9
MF:
C19H19ClN6O2
Structure:
Chemical Name:
Ixazomib citrate
CAS:
1239908-20-3
MF:
C20H23BCl2N2O9
Structure:
Chemical Name:
Fezolinetant
CAS:
1629229-37-3
MF:
C16H15FN6OS
Structure:
Chemical Name:
EC330
CAS:
2016795-77-8
MF:
C30H32F2O2
Structure:
Chemical Name:
GDC-0077
CAS:
2060571-02-8
MF:
C18H19F2N5O4
Structure:
Chemical Name:
Calcium 2-oxoglutarate
CAS:
71686-01-6
MF:
C5H8CaO5
Chemical Name:
APREMILAST (PDE inhibitor)
Structure:
Chemical Name:
RU.521
CAS:
2262452-06-0
MF:
C19H12Cl2N4O3
Structure:
Chemical Name:
CPI-444
CAS:
1202402-40-1
MF:
C20H21N7O3
Structure:
Chemical Name:
SR9009
CAS:
1379686-30-2
MF:
C20H24ClN3O4S
Structure:
Chemical Name:
PTP Inhibitor V, PHPS1
CAS:
314291-83-3
MF:
C21H15N5O6S
Structure:
Chemical Name:
ERDAFITINIB
CAS:
1346242-81-6
MF:
C25H30N6O2
Structure:
Chemical Name:
CPI 360
CAS:
1802175-06-9
MF:
C25H31N3O4
Structure:
Chemical Name:
SDZ 33-243
CAS:
83602-41-9
MF:
C64H113N11O13
Structure:
Chemical Name:
BMS-502
CAS:
2407854-18-4
Structure:
Chemical Name:
Furamidine dihydrochloride
CAS:
55368-40-6
MF:
C18H16N4O
Structure:
Chemical Name:
SB218078
CAS:
135897-06-2
MF:
C24H15N3O3
Structure:
Chemical Name:
Azacosterol dihydrochloride
CAS:
1249-84-9
MF:
C25H45ClN2O
Structure:
Chemical Name:
2''-(5-ETHYL-3,4-DIPHENYL-PYRAZOL-1-YL)-BIPHENYL-3-YLOXY]ACETIC ACID
CAS:
300657-03-8
MF:
C31H26N2O3
Structure:
Chemical Name:
N-(2-Hydroxyethyl)-N-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxamide HCl
CAS:
1219976-29-0
MF:
C10H17ClN4O2
Structure:
Chemical Name:
Clascoterone
CAS:
19608-29-8
MF:
C24H34O5
Structure:
Chemical Name:
XL518
CAS:
934660-93-2
MF:
C21H21F3IN3O2
Structure:
Chemical Name:
Tucatinib
CAS:
937263-43-9
MF:
C26H24N8O2
Structure:
Chemical Name:
Peficitinib
CAS:
944118-01-8
MF:
C18H22N4O2
Structure:
Chemical Name:
FMoc-Val-Cit-PAB-MMAE
CAS:
1350456-56-2
MF:
C73H104N10O14
Structure:
Chemical Name:
Ivosidenib
CAS:
1448347-49-6
MF:
C28H22ClF3N6O3
Structure:
Chemical Name:
GNE-140 (racemate)
CAS:
1802977-61-2
MF:
C25H23ClN2O3S2
Structure:
Chemical Name:
PF-06882961
CAS:
2230198-02-2
MF:
C31H30FN5O4
Structure:
Chemical Name:
Delgocitinib
CAS:
1263774-59-9
MF:
C16H18N6O
Structure:
Chemical Name:
LOXO-292
CAS:
2152628-33-4
MF:
C29H31N7O3
Structure:
Chemical Name:
Osilodrostat phosphate
CAS:
1315449-72-9
MF:
C13H13FN3O4P
Structure:
Chemical Name:
Tetraacetylphytosphingosine
CAS:
13018-48-9
MF:
C26H47NO7
Structure:
Chemical Name:
Pirtobrutinib
CAS:
2101700-15-4
MF:
C22H21F4N5O3
Structure:
Chemical Name:
DPO-1
CAS:
43077-30-1
MF:
C22H29OP
Structure:
Chemical Name:
Berotralstat hydrochloride
CAS:
1809010-52-3
MF:
C30H27ClF4N6O
Structure:
Chemical Name:
IA-14069
CAS:
2271216-04-5
MF:
C20H15ClF2O4
Structure:
Chemical Name:
APG-2449
CAS:
2196186-84-0
MF:
C33H42ClN5O4S
Structure:
Chemical Name:
FHD-286
CAS:
2671128-05-3
MF:
C24H30N6O6S2
Structure:
Chemical Name:
Maytansinol
CAS:
57103-68-1
MF:
C28H37ClN2O8
Structure:
Chemical Name:
Pixantrone Dimaleate
CAS:
144675-97-8
MF:
C21H23N5O6
Structure:
Chemical Name:
HRX-0215
CAS:
2369583-33-3
MF:
C21H17F2N5O3S
Structure:
Chemical Name:
PE 22-28
CAS:
1801959-12-5
MF:
C35H55N11O9
Structure:
Chemical Name:
Alisol C 23-acetate
CAS:
26575-93-9
MF:
C32H48O6
Structure:
Chemical Name:
Crisaborole
CAS:
906673-24-3
MF:
C14H10BNO3
Structure:
Chemical Name:
Donafenib
CAS:
1130115-44-4
MF:
C21H16ClF3N4O3
Structure:
Chemical Name:
6-Amino-8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-N-(1-methylethyl)-9H-purine-9-propanamine
CAS:
873436-91-0
MF:
C18H21IN6O2S
Structure:
Chemical Name:
(+)-Cloprostenol isopropyl ester
CAS:
157283-66-4
MF:
C25H35ClO6
Structure:
Chemical Name:
Gefapixant
CAS:
1015787-98-0
MF:
C14H19N5O4S
Structure:
Chemical Name:
Quizartinib hydrochloride
CAS:
1132827-21-4
MF:
C29H33ClN6O4S
Structure:
Chemical Name:
Omadacycline
CAS:
389139-89-3
MF:
C29H40N4O7
Structure:
Chemical Name:
Sarecycline Hydrochloride
CAS:
1035979-44-2
MF:
C24H30ClN3O8
Structure:
Chemical Name:
Relugolix
CAS:
737789-87-6
MF:
C29H27F2N7O5S
Structure:
Chemical Name:
(±)-alpha-[[(tert-butyl)amino]methyl]-7-ethyl-2-benzofuranmethanol hydrochloride
CAS:
60398-91-6
MF:
C16H24ClNO2
Structure:
Chemical Name:
Theodrenaline
CAS:
13460-98-5
MF:
C17H21N5O5
Structure:
Chemical Name:
MT1 BET inhibitor
CAS:
2060573-82-0
MF:
C54H66Cl2N10O9S2
Structure:
Chemical Name:
Medetomidine
CAS:
86347-14-0
MF:
C13H16N2
Structure:
Chemical Name:
E7130
CAS:
2220148-40-1
MF:
C58H83NO17
Structure:
Chemical Name:
Plitidepsin
CAS:
137219-37-5
MF:
C57H87N7O15
Structure:
Chemical Name:
Teneligliptin
CAS:
760937-92-6
MF:
C22H30N6OS
Structure:
Chemical Name:
Probenecid sodium
CAS:
23795-03-1
MF:
C13H18NNaO4S
Structure:
Chemical Name:
LC242
CAS:
187585-64-4
MF:
C37H36O14
Structure:
Chemical Name:
tesofensine
CAS:
195875-84-4
MF:
C17H23Cl2NO
Structure:
Chemical Name:
Atosiban Acetate
CAS:
914453-95-5
MF:
C45H71N11O14S2
Structure:
Chemical Name:
Rolapitant
CAS:
552292-08-7
MF:
C25H26F6N2O2
Structure:
Chemical Name:
Temsavir
CAS:
701213-36-7
MF:
C24H23N7O4
Structure:
Chemical Name:
Flumatinib mesylate
CAS:
895519-91-2
MF:
C30H33F3N8O4S
Structure:
Chemical Name:
SR9011
CAS:
1379686-29-9
MF:
C23H31ClN4O3S
Structure:
Chemical Name:
ACT-132577
CAS:
1103522-45-7
MF:
C16H14Br2N6O4S
Structure:
Chemical Name:
Sparsentan
CAS:
254740-64-2
MF:
C32H40N4O5S
Structure:
Chemical Name:
Ilaprazole sodium
CAS:
172152-50-0
MF:
C19H19N4NaO2S
Structure:
Chemical Name:
Pamiparib
CAS:
1446261-44-4
MF:
C16H15FN4O
Structure:
Chemical Name:
Rupatadine
CAS:
158876-82-5
MF:
C26H26ClN3
Structure:
Chemical Name:
Abrocitinib
CAS:
1622902-68-4
MF:
C14H21N5O2S
Chemical Name:
SD208 (TGF-Β/SMAD inhibitor)
Chemical Name:
APREPITANT (SUBSTANCE P antagonist)
Structure:
Chemical Name:
Marilixibat chloride
CAS:
228113-66-4
MF:
C40H56ClN3O4S
Structure:
Chemical Name:
FAPI-4
CAS:
2374782-02-0
MF:
C40H54F2N10O10
Structure:
Chemical Name:
MRGPRX1 agonist 1
CAS:
2377379-39-8
MF:
C23H21N3O4S
Structure:
Chemical Name:
Frovatriptan Succinate
CAS:
158930-09-7
MF:
C18H23N3O5
Structure:
Chemical Name:
BI-2493
CAS:
2937344-16-4
MF:
C24H27N7OS
Structure:
Chemical Name:
Romiplostim
CAS:
267639-76-9
MF:
C15H14N2O
Structure:
Chemical Name:
4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione
CAS:
865854-05-3
MF:
C19H14N2O2S
Structure:
Chemical Name:
VcMMAE
CAS:
646502-53-6
MF:
C68H105N11O15
Structure:
Chemical Name:
TAS-116
CAS:
1260533-36-5
MF:
C25H26N8O
Structure:
Chemical Name:
PLX3397 (Pexidartinib)
CAS:
1029044-16-3
MF:
C20H15ClF3N5
Structure:
Chemical Name:
(2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid
CAS:
1335316-40-9
MF:
C13H22N2O5
Structure:
Chemical Name:
Acalabrutinib
CAS:
1420477-60-6
MF:
C26H23N7O2
Structure:
Chemical Name:
DM4
CAS:
796073-69-3
MF:
C38H54ClN3O10S
Structure:
Chemical Name:
R-(+)-Etomoxir
CAS:
124083-20-1
MF:
C17H23ClO4
Chemical Name:
Secukinumab
CAS:
875356-43-7
Structure:
Chemical Name:
​Cedazuridine
CAS:
1141397-80-9
MF:
C9H14F2N2O5
Structure:
Chemical Name:
dCBP-1
CAS:
2484739-25-3
MF:
C51H63F2N11O10
Structure:
Chemical Name:
BMS-P5
CAS:
1549811-36-0
MF:
C27H33ClN6O2
Structure:
Chemical Name:
MRTX-1719
CAS:
2630904-45-7
MF:
C23H18ClFN6O2
Structure:
Chemical Name:
Fmoc-GGFG-Dxd
CAS:
1599440-11-5
MF:
C57H55FN8O12
Structure:
Chemical Name:
Gadobutrol
CAS:
138071-82-6
MF:
C18H31N4O9.Gd
Structure:
Chemical Name:
MK-677
CAS:
159634-47-6
MF:
C27H36N4O5S
Structure:
Chemical Name:
B7-33 2mg/5mg/10mg
CAS:
1818415-56-3
MF:
C131H229N41O36S
Chemical Name:
Cibinetide 10mg
Structure:
Chemical Name:
Aplysin
CAS:
6790-63-2
MF:
C15H19BrO